Stock SYNCOMF SYNCOM FORMULATIONS (INDIA) LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Syncom Formulations (India) Limited

Equities

SYNCOMF

INE312C01025

Delayed Bombay S.E.
Other stock markets
 09:26:59 03/06/2024 BST 		5-day change 1st Jan Change
12.01 INR +0.25% Intraday chart for Syncom Formulations (India) Limited -5.12% -19.95%
05-17 Syncom Formulations Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI
05-17 Syncom Formulations Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
SYNCOM FORMULATIONS (INDIA) LIMITED Stock Syncom Formulations (India) Limited
 135M - - - - -
ELI LILLY AND COMPANY Stock Eli Lilly and Company
 739B
NOVO NORDISK A/S Stock Novo Nordisk A/S
 598B
JOHNSON & JOHNSON Stock Johnson & Johnson
 353B
MERCK & CO., INC. Stock Merck & Co., Inc.
 318B
ABBVIE INC. Stock AbbVie Inc.
 285B
  1. Stock Market
  2. Equities
  3. SYNCOMF Stock
  4. Charts Syncom Formulations (India) Limited
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW